Understanding EMPA-REG OUTCOME

Lancet Diabetes Endocrinol. 2015 Dec;3(12):928-9. doi: 10.1016/S2213-8587(15)00424-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucosides / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents